混合细胞外囊-脂质体纳米颗粒与目标细胞的功能相互作用:没有毒性
bioRxiv : the preprint server for biology
|March 31, 2025
概括
研究人员通过将生物EV与合成脂质相结合,开发出混合细胞外囊泡 (HEV). 这些HEV显示改善了药物输送,匹配脂质纳米粒子 (LNP) 疗效与降低毒性.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 细胞生物学 细胞生物学
背景情况:
- 像脂质纳米粒子 (LNP) 和细胞外囊泡 (EV) 这样的药物输送平台在器官特异性,负载能力和稳定性方面面临挑战.
- 高效的货物交换需要囊泡与细胞之间的相互作用和膜透性,这对于EV和LNP都至关重要.
研究的目的:
- 设计混合电动汽车 (HEV),将生物电动汽车和合成LNP的优势合并为增强药物输送.
- 通过装载载着mRNA的合成脂质体的EV来创建一个组合性交付平台.
主要方法:
- 使用带有阳性电荷的脂质体,装载着对光蛋白进行编码的mRNA,制定和特征化HEV.
- 利用了基于LNP的mRNA疫苗的知识,用于HEV配方.
- 进行了体外和体外测试,以评估HEV性能.
主要成果:
- HEV的转染效率与复杂的合成LNP相美.
- 与传统的LNP相比,HEVs的细胞毒性显著降低.
- 该研究强调了HEV作为更安全,更有效的配送车辆的潜力.
结论:
- 混合电动汽车为药物输送提供了一个有希望的新平台,它结合了生物和合成组件.
- 这种方法可能特别适用于增强诸如囊性纤维化等疾病的肺先天免疫力.
- 未来的策略可能涉及患者衍生的EVs与合成脂质混合,用于向的治疗交付.
更多相关视频
00:11Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
23.5K
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
575
相关概念视频
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
